(Q48224285)

9 February 2018

title

Merosin-deficient congenital muscular dystrophy associated with abnormal cerebral cortical gyration: an autopsy study (English)

1 reference

9 February 2018

congenital muscular dystrophy

1 reference

1 reference

Taratuto AL

1

1 reference

9 February 2018

Lubieniecki F

2

1 reference

9 February 2018

Díaz D

3

1 reference

9 February 2018

Schultz M

4

1 reference

9 February 2018

Ruggieri V

5

1 reference

9 February 2018

Saccoliti M

6

1 reference

9 February 2018

Dubrovsky A

7

1 reference

9 February 2018

publication date

1 March 1999

1 reference

9 February 2018

published in

Neuromuscular Disorders

1 reference

9 February 2018

volume

9

1 reference

9 February 2018

issue

2

1 reference

9 February 2018

page(s)

86-94

1 reference

9 February 2018

Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900112-6

7 January 2021

Somatosensory and visual evoked potentials in congenital muscular dystrophy: correlation with MRI changes and muscle merosin status

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900112-6

7 January 2021

Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900112-6

7 January 2021

Congenital progressive muscular dystrophy of the Fukuyama type - clinical, genetic and pathological considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900112-6

7 January 2021

Diagnostic criteria for Walker-Warburg syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900112-6

7 January 2021

Merosin-negative congenital muscular dystrophy associated with extensive brain abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900112-6

7 January 2021

Merosin-negative congenital muscular dystrophy, occipital epilepsy with periodic spasms and focal cortical dysplasia. Report of three Italian cases in two families.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900112-6

7 January 2021

Magnetic resonance imaging in classification of congenital muscular dystrophies with brain abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900112-6

7 January 2021

Presence of Laminin 5 Chain and Lack of Laminin 1 Chain during Human Muscle Development and in Muscular Dystrophies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900112-6

7 January 2021

Sequential study of central and peripheral nervous system involvement in an infant with merosin-deficient congenital muscular dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900112-6

7 January 2021

Localization of laminin alpha 2 chain in normal human central nervous system: an immunofluorescence and ultrastructural study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900112-6

7 January 2021

Are breaches in the glia limitans the primary cause of the micropolygyria in Fukuyama-type congenital muscular dystrophy (FCMD)? Pathological study of the cerebral cortex of an FCMD fetus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900112-6

7 January 2021

Pial-glial barrier abnormalities in fetuses with Fukuyama congenital muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900112-6

7 January 2021

Localization of laminin subunits in the central nervous system in Fukuyama congenital muscular dystrophy: an immunohistochemical investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900112-6

7 January 2021

Diagnosis of merosin (laminin-2) deficient congenital muscular dystrophy by skin biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900112-6

7 January 2021

Expression of laminin chains in skin in merosin-deficient congenital muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900112-6

7 January 2021

Immunohistochemical study of merosin-negative congenital muscular dystrophy: laminin alpha 2 deficiency in skin biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900112-6

7 January 2021

Intracellular detection of laminin alpha 2 chain in skin by electron microscopy immunocytochemistry: comparison between normal and laminin alpha 2 chain deficient subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900112-6

7 January 2021

Basement membrane abnormality in merosin-negative congenital muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900112-6

7 January 2021

Disruption of muscle basal lamina in congenital muscular dystrophy with merosin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900112-6

7 January 2021

Demyelinating peripheral neuropathy in merosin-deficient congenital muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900112-6

7 January 2021

Peripheral nerve involvement in merosin-deficient congenital muscular dystrophy and dy mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900112-6

7 January 2021

Localization of the laminin alpha 2 chain in normal human skeletal muscle and peripheral nerve: an ultrastructural immunolabeling study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900112-6

7 January 2021

10.1016/S0960-8966(98)00112-6

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018